0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Psychopharmacology
 41-60 of 327 Articles
JAMA | 
Original Investigation |  FREE
Elizabeth D. Kantor, PhD, MPH; Colin D. Rehm, PhD, MPH; Jennifer S. Haas, MD, MSc; et al.
JAMA. 2015;314(17):1818-1830. doi:10.1001/jama.2015.13766.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Erica S. Weitz, MA; Steven D. Hollon, PhD; Jos Twisk, PhD; et al.
JAMA Psychiatry. 2015;72(11):1102-1109. doi:10.1001/jamapsychiatry.2015.1516.
Includes: Supplemental Content

JAMA Psychiatry | 
Editorial | 
Maurizio Fava, MD
JAMA Psychiatry. 2015;72(11):1073-1074. doi:10.1001/jamapsychiatry.2015.1727.

JAMA Psychiatry | 
Original Investigation | 
Marta Peciña, MD, PhD; Amy S. B. Bohnert, PhD; Magdalena Sikora, BS; et al.
JAMA Psychiatry. 2015;72(11):1087-1094. doi:10.1001/jamapsychiatry.2015.1335.
Includes: Supplemental Content

JAMA Psychiatry | 
Viewpoint | 
Patricio O’Donnell, MD, PhD; Michael D. Ehlers, MD, PhD
JAMA Psychiatry. 2015;72(11):1067-1068. doi:10.1001/jamapsychiatry.2015.1735.

JAMA Internal Medicine | 
Invited Commentary | 
Kurt Kroenke, MD
JAMA Intern Med. 2015;175(11):1770-1772. doi:10.1001/jamainternmed.2015.5243.

JAMA Internal Medicine | 
Original Investigation | 
Annie LeBlanc, PhD; Jeph Herrin, PhD; Mark D. Williams, MD; et al.
JAMA Intern Med. 2015;175(11):1761-1770. doi:10.1001/jamainternmed.2015.5214.
Includes: Supplemental Content

JAMA Internal Medicine | 
Teachable Moment | 
Claire K. Larson, MD; Helen Kao, MD
JAMA Intern Med. 2015;175(11):1750-1751. doi:10.1001/jamainternmed.2015.5253.

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;314(13):1331. doi:10.1001/jama.2015.12352.

JAMA Ophthalmology | 
Brief Report | 
Richard J. Symes, BSc(Hons), FRCOphth; Mahyar Etminan, PharmD, MSc; Frederick S. Mikelberg, MD, FRCSC
JAMA Ophthalmol. 2015;133(10):1187-1189. doi:10.1001/jamaophthalmol.2015.2180.

JAMA Psychiatry | 
Viewpoint | 
Bronwyn M. Graham, PhD/MPsychol(Clin); Rick Richardson, PhD
JAMA Psychiatry. 2015;72(10):959-960. doi:10.1001/jamapsychiatry.2015.1187.

JAMA Psychiatry | 
Original Investigation | 
Stephen F. Smagula, PhD; Meryl A. Butters, PhD; Stewart J. Anderson, PhD; et al.
JAMA Psychiatry. 2015;72(10):1021-1028. doi:10.1001/jamapsychiatry.2015.1324.
Includes: Supplemental Content

JAMA Psychiatry | 
Editorial | 
David Goldman, MD
JAMA Psychiatry. 2015;72(10):969-970. doi:10.1001/jamapsychiatry.2015.1332.

JAMA Psychiatry | 
Editorial | 
Amit Shah, MD, MSCR; Viola Vaccarino, MD, PhD
JAMA Psychiatry. 2015;72(10):964-965. doi:10.1001/jamapsychiatry.2015.1394.

JAMA Psychiatry | 
Research Letter | 
Gregory E. Simon, MD, MPH; Karen J. Coleman, PhD; Beth E. Waitzfelder, PhD; et al.
JAMA Psychiatry. 2015;72(10):1055-1056. doi:10.1001/jamapsychiatry.2015.1437.

JAMA Psychiatry | 
Original Investigation | 
Kimberly A. Yonkers, MD; Susan G. Kornstein, MD; Ralitza Gueorguieva, PhD; et al.
JAMA Psychiatry. 2015;72(10):1037-1044. doi:10.1001/jamapsychiatry.2015.1472.
Includes: Supplemental Content

JAMA Internal Medicine | 
Perspective | 
Mary K. Brennan-Taylor, BA
JAMA Intern Med. 2015;175(9):1441. doi:10.1001/jamainternmed.2015.3659.

JAMA Psychiatry | 
Editorial | 
Christoph U. Correll, MD; Joseph C. Blader, PhD
JAMA Psychiatry. 2015;72(9):859-860. doi:10.1001/jamapsychiatry.2015.0632.

JAMA Psychiatry | 
Original Investigation | 
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Psychiatry. 2015;72(9):867-874. doi:10.1001/jamapsychiatry.2015.0500.
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Psychiatry. 2015;72(9):927-934. doi:10.1001/jamapsychiatry.2015.0891.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Research Letter  | 
Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014
Mehmet Burcu, MS; Julie M. Zito, PhD; Leanne Metcalfe, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA Psychiatry
Editorial  | 
What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder
Gerard Sanacora, MD, PhD